Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Mifamurtide & Osteosarcoma (OS), Mifamurtide is EMA‑approved, but not FDA‑approved, for osteosarcoma. It has European marketing authorization as part of adjuvant treatment for non‑metastatic, resectable, high‑grade osteosarcoma in children, adolescents, and young adults (1, 2)
A prospective single centre survival analysis of a mifamurtide addition to conventional therapy in 23 patients over a 5.5 year enrolment period and compared to a historical control of 26 patient with localized disease revealed that the addition of mifamurtide could be considered as a best treatment…